Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
ABII (NASDAQ: ABII)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Premium News
Press Releases
SEC
Abraxis BioScience Reports 2009 Third Quarter Financial Results
Nov 05, 2009 08:15 AM |
ABRAXANE(R) Receives Orphan Drug Status for the Treatment of Pancreatic Cancer and Stage IIB-IV Melanoma
Nov 05, 2009 08:01 AM |
Abraxis Health Dedicates State of the Art Nanotechnology & Biologics Facility in Phoenix, Arizona
Nov 04, 2009 08:15 PM |
WPI
Abraxis BioScience Announces Date for 2009 Third Quarter Financial Results and Investor Conference Call
Oct 16, 2009 08:05 AM |
Abraxis BioScience to Present at the Merriman Curhan Ford Investor Summit and Lazard Capital Markets Healthcare Conference
Oct 16, 2009 08:05 AM |
LAEDC's 14th Annual Eddy Awards(R) Honors Dr. Patrick Soon-Shiong and The Boeing Company for Business Leadership
Sep 23, 2009 03:00 AM |
BA
Abraxis Bioscience to Present at the Robert W. Baird 2009 Healthcare Conference and Bank of America Merrill Lynch 2009 Smid Conference
Sep 02, 2009 08:05 AM |
BAC
FDA Calendar Updates: ABII, BMRN, JNJ, OSIP, Roche
Jul 13, 2009 03:29 PM |
BMRN
,
JNJ
,
OSIP
The Week in Review: China Biomedical Investment
Jul 20, 2008 02:55 PM |
BJGP
,
GTEC
Abraxis to Appeal Jury Ruling on Elan Patent Infringement Claim and Exelixis Presents Clinical Data Supporting the Safety and Initial Clinical Activity of XL228 in Chronic and Acute Leukemia
Jun 16, 2008 08:59 AM |
EXEL
,
HNAB
More..
State Funds C.R., Oelwein Projects
Dec 20, 2008 01:54 PM |
SE
More..
StockPreacher.com Issues Trading Outlook for Cell Therapeutics Inc.
Aug 19, 2009 06:51 AM |
CTIC
,
GILD
,
TEVA
Abraxis BioScience Reports 2009 Second Quarter Financial Results
Aug 06, 2009 08:24 AM |
Results from a Phase 2 Study of ABRAXANE® In Combination With Carboplatin Show Clinical Activity in the First Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer
Aug 03, 2009 10:08 AM |
Abraxis BioScience Announces Date for 2009 Second Quarter Financial Results and Investor Conference Call
Jul 23, 2009 08:18 AM |
CORRECTING and REPLACING Abraxis BioScience Completes Enrollment of Pivotal Phase III Advanced Lung Cancer Study Evaluating ABRAXANE® Vs. Taxol®
Jul 14, 2009 02:46 PM |
Abraxis BioScience Names Mary Lynne Hedley, Ph.D., Executive Vice President of Operations and Chief Scientific Officer
Jul 13, 2009 08:42 AM |
Abraxis BioScience Completes Enrollment of Pivotal Phase III Advanced Lung Cancer Study Evaluating ABRAXANE® Vs. Taxol®
Jul 13, 2009 07:34 AM |
Abraxis BioScience Appoints Rick Rodgers Chief Financial Officer
Jul 10, 2009 08:06 AM |
ABRAXANE Approved for Advanced Breast Cancer Patient Treatment in Quebec
Jun 29, 2009 08:33 AM |
Abraxis Bioscience Launches ABRAXANE® in China for Women with Metastatic Breast Cancer
Jun 11, 2009 10:01 PM |
More..
Form 4 Abraxis BioScience, Inc. For: Nov 10 Filed by: Wendel Bruce (10K)
Nov 12, 2009 06:37 PM
Form 3 Abraxis BioScience, Inc. For: Sep 24 Filed by: Michele B. Soon-Shiong 2009 Grantor Retained Annuity Trust 1 UAD 9/24/2009 (10K)
Oct 05, 2009 07:29 PM
Form 3 Abraxis BioScience, Inc. For: Sep 24 Filed by: Michele B. Soon-Shiong 2009 Grantor Retained Annuity Trust 2 UAD 9/24/2009 (10K)
Oct 05, 2009 07:27 PM
Form 3 Abraxis BioScience, Inc. For: Sep 24 Filed by: Patrick Soon-Shiong 2009 Grantor Annuity Trust 2 UAD 9/24/2009 (10K)
Oct 05, 2009 07:25 PM
Form 3 Abraxis BioScience, Inc. For: Sep 24 Filed by: Patrick Soon-Shiong 2009 Grantor Retained Annuity Trust 1 UAD 9/24/2009 (10K)
Oct 05, 2009 07:23 PM
Form 4 Hedley Mary Lynne For: Jul 13 (10K)
Jul 15, 2009 08:03 PM
Form 4 Rodgers Richard J For: Jul 13 (10K)
Jul 15, 2009 08:03 PM
Form 3 Hedley Mary Lynne For: Jul 09 (10K)
Jul 15, 2009 08:02 PM
Form 3 Rodgers Richard J For: Jul 09 (10K)
Jul 15, 2009 08:02 PM
Form 4 MOULDER LEON O JR For: Apr 29 (10K)
May 01, 2009 06:44 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
ABII
Compare to S&P
YTD
-46.59 %
-55.80 %
4 Weeks
12.78 %
7.07 %
12 Weeks
35.63 %
26.30 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-18.97 %
EPS Growth in Last Year:
-2,200.00 %
Sales Growth in Last Quarter:
28.57 %
Sales Growth in Last Quarter:
3.48 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
